Product
Cladribine + Homoharringtonine + Cytarabine
1 clinical trial
2 indications
Indication
Acute Myeloid LeukemiaIndication
AdultClinical trial
A Monocenter Prospective Single Arm Study of Cladribine Plus Homoharringtonine and Cytarabine Regimen (CHA) for Induced Therapy in Adults de Novo Acute Myeloid Leukemia (Non-M3)Status: Recruiting, Estimated PCD: 2024-12-31